# Adenosin to Rapidly Reverse Left Ventricle Impairment in Takotsubo Syndrome

> **NCT02867878** · PHASE2 · TERMINATED · sponsor: **University Hospital of Ferrara** · enrollment: 5 (actual)

## Conditions studied

- Takotsubo Cardiomyopathy
- Takotsubo Syndrome

## Interventions

- **DRUG:** Adenosine
- **DRUG:** Saline solution

## Key facts

- **NCT ID:** NCT02867878
- **Lead sponsor:** University Hospital of Ferrara
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-08
- **Primary completion:** 2018-10
- **Final completion:** 2018-10
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** inability to recruiti a sufficient number of patients
- **Last updated:** 2018-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02867878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02867878, "Adenosin to Rapidly Reverse Left Ventricle Impairment in Takotsubo Syndrome". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02867878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*